Neumentum, Inc.

SUMMIT, NJ · Founded 2017 · CIK 0001720959 · Biotech · Private

Non-opioid analgesic and neurology pharmaceuticals

neumentum.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$27M
5 Form D · Oct 2021
60 months since last filing
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,260,000
Private capital raisedForm D · SEC$5,000,000
Private capital raisedForm D · SEC$1,050,000
Private capital raisedForm D · SEC$2,663,000
Private capital raisedForm D · SEC$13,300,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1165ABALONE BIO, INC.——
1166Arcus Biosciences——
1167LARIX BIOSCIENCE LLC——
1168Neumentum, Inc.—$27M
1169Tioga Pharmaceuticals Inc—$24M
1170KODIAK BP, LLC—$13M
1171Nova Mentis Life Science Corp.—$188K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Andrew BlankDirector
  • Christine CvijicDirector · Executive Officer
  • Pedro GranadilloDirector
  • Taggart McGurrinExecutive Officer
  • August MorettiDirector
  • Joseph PergolizziDirector
  • Richard ShivelyDirector · Executive Officer
  • Ilona SteigerwaldExecutive Officer

Patents

USPTO · 0 granted of 4
  • Compositions And Methods For Treating Pain And/or Inflammationapplication
  • Compositions And Methods For Treating Pain And/or Inflammationapplication
  • Compositions And Methods For Treating Pain And/or Inflammationapplication
  • Compositions And Methods For Treating Painapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.